Immix Biopharma, Inc. (IMMX)
NASDAQ: IMMX · Real-Time Price · USD
5.56
+0.72 (14.88%)
At close: Dec 5, 2025, 4:00 PM EST
5.67
+0.11 (1.97%)
After-hours: Dec 5, 2025, 7:56 PM EST
Immix Biopharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 187 | 61 | 137 | 32 | 47 | - | |
| Market Cap Growth | 299.23% | -55.98% | 331.07% | -32.18% | - | - | |
| Enterprise Value | 172 | 42 | 118 | 15 | 51 | - | |
| Last Close Price | 5.56 | 2.20 | 6.92 | 2.29 | 3.56 | - | |
| PB Ratio | 22.22 | 4.57 | 8.49 | 2.42 | 2.61 | - | |
| P/TBV Ratio | 22.59 | 4.57 | 8.38 | 2.42 | 2.61 | - | |
| Debt / Equity Ratio | 0.13 | 0.08 | - | - | 0.00 | -0.87 | |
| Quick Ratio | 1.47 | 2.26 | 5.02 | 10.75 | 87.46 | 0.10 | |
| Current Ratio | 1.53 | 2.33 | 5.32 | 11.70 | 90.01 | 0.10 | |
| Return on Equity (ROE) | -182.55% | -147.33% | -106.22% | -52.84% | -367.80% | - | |
| Return on Assets (ROA) | -66.48% | -66.11% | -57.92% | -31.04% | -9.02% | -38.27% | |
| Return on Capital (ROIC) | -107.33% | -92.84% | -68.71% | -32.93% | -9.71% | - | |
| Return on Capital Employed (ROCE) | -260.60% | -159.00% | -99.60% | -60.30% | -7.50% | 9.60% | |
| Earnings Yield | -12.62% | -35.72% | -11.22% | -25.80% | -51.85% | - | |
| FCF Yield | -8.28% | -26.06% | -8.31% | -23.23% | -3.38% | - | |
| Buyback Yield / Dilution | -15.04% | -63.11% | -24.87% | -278.13% | -8.82% | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.